Accelerated hypofractionated intensity modulated radiotherapy with concurrent and adjuvant temozolomide for patients with glioblastoma multiforme: A safety and efficacy analysis

被引：0
|
作者：
Panet-Raymond, V. [1 ]
Roberge, D. [1 ]
Sonhami, L. [1 ]
Shakibnia, L. [1 ]
Kavan, P. [1 ]
Muanza, T. [1 ]
Lambert, C. [1 ]
Guiot, M. C. [1 ]
Shenouda, G. [1 ]
机构：
[1] McGill Univ, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2007年 / 69卷 / 03期
关键词：
D O I：
10.1016/j.ijrobp.2007.07.1245
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S245 / S246
页数：2
相关论文
共 50 条
  • [21] Hypofractionated radiotherapy (XRT) plus concurrent and adjuvant versus salvage temozolomide (TMZ) in elderly patients with glioblastoma multiforme: A retrospective review
    Cao, Jeffrey
    Bauman, Glenn
    Fisher, Barbara
    Macdonald, David
    Megyesi, Joseph
    Watling, Chris
    NEURO-ONCOLOGY, 2007, 9 (04) : 582 - 582
  • [22] Hypofractionated radiotherapy (XRT) plus concurrent and adjuvant versus salvage temozolomide (TMZ) in elderly patients with glioblastoma multiforme: A retrospective review
    Cao, J.
    Bauman, G.
    Fisher, B.
    Macdonald, D.
    Megyesi, J.
    Watling, C.
    RADIOTHERAPY AND ONCOLOGY, 2007, 84 : S41 - S41
  • [23] Toxicity of concurrent and adjuvant temozolomide in patients with glioblastoma multiforme (GBM).
    Mcmahon, David
    Hussein, Awab
    Mangleburg, Hunter
    Nichianain, Aine
    Fitzpatrick, Orla
    McLaughlin, Ronan Andrew
    Conroy, Michael R.
    Marks, Sam Jonathan
    Naidoo, Jarushka
    Grogan, William
    Murphy, Adrian Gerard
    Breathnach, Oscar S.
    Hennessy, Bryan T.
    Morris, Patrick G.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [24] Glioblastoma in elderly patients: Safety and efficacy of adjuvant radiotherapy with concomitant temozolomide
    Fiorica, F.
    Berretta, M.
    Colosimo, C.
    Stefanelli, A.
    Ursino, S.
    Zanet, E.
    Palmucci, T.
    Maugeri, D.
    Malaguarnera, M.
    Palmucci, S.
    Grasso, M.
    Tirelli, U.
    Cartei, F.
    ARCHIVES OF GERONTOLOGY AND GERIATRICS, 2010, 51 (01) : 31 - 35
  • [25] MODERATE HYPOFRATIONATED ACCELERATED RADIOTHERAPY WITH CONCURRENT AND/OR ADJUVANT TEMOZOLOMIDE USING TOMOTHERAPY FOR PATIENTS WITH GLIOBLASTOMA
    Kim, Y.
    Cho, M.
    Kim, J.
    NEURO-ONCOLOGY, 2017, 19 : 74 - 74
  • [26] Pseudoprogression in Patients With Glioblastoma Multiforme After Concurrent Radiotherapy and Temozolomide
    Topkan, Erkan
    Topuk, Savas
    Oymak, Ezgi
    Parlak, Cem
    Pehlivan, Berrin
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2012, 35 (03): : 284 - 289
  • [27] Radiotherapy with concurrent or sequential temozolomide in elderly patients with glioblastoma multiforme
    Hashem, Sameh A.
    Salem, Ahmed
    Al-Rashdan, Abdulla
    Ezam, Najeeb
    Nour, Ala'a
    Alsharbaji, Amer
    Rejeeth, Chandrababu
    Mohamad, Issa
    Sughayer, Maher
    Elyan, Maher
    Al-Hussaini, Maysa
    Addasi, Ala'
    Almousa, Abdelatif
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2012, 56 (02) : 204 - 210
  • [28] NEOADJUVANT (PRE RADIOTHERAPY) TEMOZOLOMIDE FOLLOWED BY RADIATION THERAPY WITH CONCURRENT AND ADJUVANT TEMOZOLOMIDE IN GLIOBLASTOMA MULTIFORME
    Prajapati, Chinmaykumar
    Mehta, Maitrik
    Kunikullaya, U. Suryanarayan
    NEURO-ONCOLOGY, 2021, 23 : 45 - 45
  • [29] Radiotherapy with concomitant and adjuvant temozolomide in glioblastoma multiforme patients: Compliance analysis.
    Cartei, F.
    Carau, B.
    Ursino, S.
    Api, P.
    Fiorica, F.
    Cerruti, S.
    Cavallo, M.
    Padovani, R.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S296 - S296
  • [30] A Phase 2 Trial of Neoadjuvant Temozolomide Followed by Hypofractionated Accelerated Radiation Therapy With Concurrent and Adjuvant Temozolomide for Patients With Glioblastoma
    Shenouda, George
    Souhami, Luis
    Petrecca, Kevin
    Owen, Scott
    Panet-Raymond, Valerie
    Guiot, Marie-Christine
    Corredor, Andrea Gomez
    Abdulkarim, Bassam
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 97 (03): : 487 - 494
12345